Enfusion revenue was $195.16M for the trailing 12 months ending Sep 30, 2024, with -50% growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $51.2M, up 3.5% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ENFN annual revenue was $174.5M, with 16.1% growth year-over-year.
ENFN past revenue growth
How has ENFN's revenue growth performed historically?
On Invalid Date, Enfusion (NYSE: ENFN) reported Q3 2024 revenue of $51.17 million up 15.35% year over year. In the same quarter last year, Enfusion's revenue was $44.36 million.
What was Enfusion's revenue in 2023?
Enfusion's annual revenue for the twelve months ending Dec 31, 2023 was $174.54 million, a 16.09% increase year over year.
How much does Enfusion make in a day?
Based on Enfusion annual revenue for the past four years, ENFN makes an average of $353,526.71 per day.
What was Enfusion's annual revenue growth in the past year?
As of Q4 2024, Enfusion's revenue has grown 15.78% year over year. This is 0.73 percentage points lower than the US Software - Application industry revenue growth rate of 16.5%. Enfusion's revenue in the past year totaled $195.16 million.
How much does Enfusion make in a year?
Enfusion's revenue by year for the past four years is:
Enfusion's revenue for the twelve months ending Dec 31, 2023 was $174.54 million, a 16.09% increase year over year.
Enfusion's annual revenue for Dec 31, 2022 was $150.35 million, a 34.6% increase from 2021.
Enfusion's annual revenue for 2021 was $111.70 million, a 40.39% increase from 2020.
Enfusion's annual revenue for 2020 was $79.57 million, a 34.79% increase from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.